Search

Your search keyword '"Engelborghs, Sebastiaan"' showing total 2,313 results

Search Constraints

Start Over You searched for: Author "Engelborghs, Sebastiaan" Remove constraint Author: "Engelborghs, Sebastiaan"
2,313 results on '"Engelborghs, Sebastiaan"'

Search Results

4. Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning

6. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

7. Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer's disease

8. Involvement of the choroid plexus in Alzheimer’s disease pathophysiology: findings from mouse and human proteomic studies

9. Brain age as a biomarker for pathological versus healthy ageing – a REMEMBER study

10. Subclinical epileptiform activity in the Alzheimer continuum: association with disease, cognition and detection method

13. Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers

14. Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

17. Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease

18. Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease

19. New insights into the genetic etiology of Alzheimer’s disease and related dementias

20. Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer’s disease CSF profile of neuronal injury and inflammation

22. Accelerated Cognitive Decline Associated With Hearing Loss and Bilateral Vestibulopathy: Insights From a Prospective Cross-Sectional Study Using the Repeatable Battery for the Assessment of Neuropsychological Status Adjusted for the Hearing Impaired in the DFNA9 Population

23. Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

25. Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia

27. Attitudes toward pre-symptomatic screening for Alzheimer’s dementia in five European countries: a comparison of family members of people with Alzheimer’s dementia versus non-family members

29. Proteomic comparison between non‐purified cerebrospinal fluid and cerebrospinal fluid‐derived extracellular vesicles from patients with Alzheimer's, Parkinson's and Lewy body dementia

30. CSF proteome profiling identifies novel biomarkers for Frontotemporal Dementia and its pathological subtypes

32. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

35. Is vestibular function related to human hippocampal volume?

37. Blood-based multivariate methylation risk score for cognitive impairment and dementia

38. Evaluation of hearing levels and vestibular function and the impact on cognitive performance in (pre)-symptomatic patients with DFNA9: protocol for a prospective longitudinal study (Rosetta study)

40. Alzheimer’s disease cerebrospinal fluid biomarker in cognitively normal subjects

41. Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay

42. Pre-analytical stability of novel cerebrospinal fluid biomarkers

45. Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia: A Meta-analysis

47. Inflammatory biomarkers in Alzheimer's disease plasma

48. Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort

49. Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum

50. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.

Catalog

Books, media, physical & digital resources